We next tested the efficacy of these CAR T cells in vivo and again observed that anti-TACI CAR T cells could clear the BCMA negative tumor while anti-BCMA CAR T cells were comparable to untransduced T cells (Fig. 4c–e). The gene discussed is TNFRSF17; the disease is neoplasm.